AstraZeneca's Self-administered Flu Vaccine to be Approved by FDA

FluMist, AstraZeneca's nasal spray flu vaccination that has been on the market for two decades, might be ready for self-administration as soon as next year.

Torrent Pharma Net profit Rises 24% To Rs 386 Crore

Torrent Pharmaceuticals Ltd recorded a consolidated net profit of 386 crore for the September quarter, up 24% from the previous year, while revenue increased 16% from 2,291 crore to 2,660 crore. Its earnings before interest, taxes, depreciation...

Lupin Secures US FDA Approval for Fluconazole Tablets, USP

Lupin Limited (Lupin) announced that the United States Food and Drug Administration

Roche Signs Definitive Agreement To Acquire Telavant Holdings

Roche has announced the signing of a formal agreement to purchase Telavant Holdings, Inc.

US FDA Approves Vaxcyte's IND Application For VAX-31

Vaxcyte, Inc., a vaccine innovation company that develops b>high-fidelity vaccines to protect humans from the consequences of bacterial diseases, announced that the FDA has approved the company's adult Investigational New Drug (IND)...

LMDX, AstraZeneca & Everton Partner For Heart & Lung screening Hub

LumiraDx (LMDX) Limited announced a strategic partnership with AstraZeneca and Everton in the Community to launch England's first community-based heart and lung screening hub in November. The official charity of Everton Football Club will run this...

The Future of Pharma: Embracing Continuous Manufacturing

Continuous manufacturing (CM) is a modern manufacturing trend. Industries ranging from paper to petrochemicals

US FDA Approves Tiziana's Treatment for Multiple Sclerosis

Tiziana Life Sciences Ltd., a biotechnology firm researching innovative immunomodulation medicines,

Granule India Pvt Ltd Medicine Approved by US FDA for Ulcer Treatment

The US Food and Drug Administration (FDA) have approved Granules India Limited's Abbreviated

Novo Nordisk Bags Nod To Peform Clinical Trials On Weekly Insulin

Novo Nordisk, a Danish pharmaceutical company, is preparing to test the efficacy and safety

© 2025 India Pharma Outlook. All Rights Reserved.